220 related articles for article (PubMed ID: 12966601)
1. Summarizing disease features over time: I. Adjusted mean SLEDAI derivation and application to an index of disease activity in lupus.
Ibañez D; Urowitz MB; Gladman DD
J Rheumatol; 2003 Sep; 30(9):1977-82. PubMed ID: 12966601
[TBL] [Abstract][Full Text] [Related]
2. Summarizing disease features over time: II. Variability measures of SLEDAI-2K.
Ibañez D; Gladman D; Urowitz M
J Rheumatol; 2007 Feb; 34(2):336-40. PubMed ID: 17183620
[TBL] [Abstract][Full Text] [Related]
3. Adjusted mean Systemic Lupus Erythematosus Disease Activity Index-2K is a predictor of outcome in SLE.
Ibañez D; Gladman DD; Urowitz MB
J Rheumatol; 2005 May; 32(5):824-7. PubMed ID: 15868616
[TBL] [Abstract][Full Text] [Related]
4. The effect of menopause on disease activity in systemic lupus erythematosus.
Urowitz MB; Ibañez D; Jerome D; Gladman DD
J Rheumatol; 2006 Nov; 33(11):2192-8. PubMed ID: 16981295
[TBL] [Abstract][Full Text] [Related]
5. Systemic lupus erythematosus disease activity index 2000.
Gladman DD; Ibañez D; Urowitz MB
J Rheumatol; 2002 Feb; 29(2):288-91. PubMed ID: 11838846
[TBL] [Abstract][Full Text] [Related]
6. Prediction of short term mortality in systemic lupus erythematosus with time dependent measures of disease activity.
Cook RJ; Gladman DD; Pericak D; Urowitz MB
J Rheumatol; 2000 Aug; 27(8):1892-5. PubMed ID: 10955329
[TBL] [Abstract][Full Text] [Related]
7. High predictive value of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for survival in systemic lupus erythematosus.
Nived O; Jönsen A; Bengtsson AA; Bengtsson C; Sturfelt G
J Rheumatol; 2002 Jul; 29(7):1398-400. PubMed ID: 12136895
[TBL] [Abstract][Full Text] [Related]
8. Accrual of organ damage over time in patients with systemic lupus erythematosus.
Gladman DD; Urowitz MB; Rahman P; Ibañez D; Tam LS
J Rheumatol; 2003 Sep; 30(9):1955-9. PubMed ID: 12966597
[TBL] [Abstract][Full Text] [Related]
9. SLEDAI-2K for a 30-day window.
Touma Z; Urowitz MB; Gladman DD
Lupus; 2010 Jan; 19(1):49-51. PubMed ID: 19910390
[TBL] [Abstract][Full Text] [Related]
10. Role of specialty care in the management of patients with systemic lupus erythematosus.
Urowitz MB; Kagal A; Rahman P; Gladman DD
J Rheumatol; 2002 Jun; 29(6):1207-10. PubMed ID: 12064836
[TBL] [Abstract][Full Text] [Related]
11. The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus.
Uribe AG; Vilá LM; McGwin G; Sanchez ML; Reveille JD; Alarcón GS
J Rheumatol; 2004 Oct; 31(10):1934-40. PubMed ID: 15468356
[TBL] [Abstract][Full Text] [Related]
12. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus.
Brunner HI; Gladman DD; Ibañez D; Urowitz MD; Silverman ED
Arthritis Rheum; 2008 Feb; 58(2):556-62. PubMed ID: 18240232
[TBL] [Abstract][Full Text] [Related]
13. Serum albumin as a marker for disease activity in patients with systemic lupus erythematosus.
Yip J; Aghdassi E; Su J; Lou W; Reich H; Bargman J; Scholey J; Gladman DD; Urowitz MB; Fortin PR
J Rheumatol; 2010 Aug; 37(8):1667-72. PubMed ID: 20516026
[TBL] [Abstract][Full Text] [Related]
14. Disease activity, damage and survival in Mexican patients with acute severe systemic lupus erythematosus.
Zonana-Nacach A; Yañez P; Jiménez-Balderas FJ; Camargo-Coronel A
Lupus; 2007; 16(12):997-1000. PubMed ID: 18042596
[TBL] [Abstract][Full Text] [Related]
15. European Consensus Lupus Activity Measurement is sensitive to change in disease activity in childhood-onset systemic lupus erythematosus.
Brunner HI; Silverman ED; Bombardier C; Feldman BM
Arthritis Rheum; 2003 Jun; 49(3):335-41. PubMed ID: 12794788
[TBL] [Abstract][Full Text] [Related]
16. Optimal frequency of visits for patients with systemic lupus erythematosus to measure disease activity over time.
Ibañez D; Gladman DD; Touma Z; Nikpour M; Urowitz MB
J Rheumatol; 2011 Jan; 38(1):60-3. PubMed ID: 21078718
[TBL] [Abstract][Full Text] [Related]
17. SLEDAI-2K 10 days versus SLEDAI-2K 30 days in a longitudinal evaluation.
Touma Z; Urowitz MB; Ibañez D; Gladman DD
Lupus; 2011 Jan; 20(1):67-70. PubMed ID: 21233149
[TBL] [Abstract][Full Text] [Related]
18. Damage accumulation in systemic lupus erythematosus and its relation to disease activity and mortality.
Becker-Merok A; Nossent HC
J Rheumatol; 2006 Aug; 33(8):1570-7. PubMed ID: 16845708
[TBL] [Abstract][Full Text] [Related]
19. Item weightings for the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Disease Damage Index using Rasch analysis do not lead to an important improvement.
Brunner HI; Feldman BM; Urowitz MB; Gladman DD
J Rheumatol; 2003 Feb; 30(2):292-7. PubMed ID: 12563683
[TBL] [Abstract][Full Text] [Related]
20. Do lupus disease activity measures detect clinically important change?
Fortin PR; Abrahamowicz M; Clarke AE; Neville C; Du Berger R; Fraenkel L; Liang MH
J Rheumatol; 2000 Jun; 27(6):1421-8. PubMed ID: 10852264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
